Información:
Error:
ID
41199
Descripción
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01363817
Link
https://clinicaltrials.gov/show/NCT01363817
Palabras clave
Versiones (1)
- 11/7/20 11/7/20 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
11 de julio de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Lymphoblastic Leukemia, Acute T-cell NCT01363817
Eligibility Lymphoblastic Leukemia, Acute T-cell NCT01363817
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoblastic Leukemia, Acute T-cell NCT01363817
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Refractory T Acute Lymphoblastic Leukemia | Refractory T Lymphoblastic Lymphoma | Acute lymphoblastic leukemia recurrent | T-lymphoblastic lymphoma recurrent | Status post Standard therapy
Item
subjects with t-cell acute lymphoblastic leukemia or t-cell lymphoblastic lymphoma refractory to or relapsed from standard therapies
boolean
C4725790 (UMLS CUI [1])
C1335731 (UMLS CUI [2])
C1504525 (UMLS CUI [3])
C0862284 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C2936643 (UMLS CUI [5,2])
C1335731 (UMLS CUI [2])
C1504525 (UMLS CUI [3])
C0862284 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C2936643 (UMLS CUI [5,2])
Life Expectancy
Item
life expectancy of at least 2 months
boolean
C0023671 (UMLS CUI [1])
Performance Status
Item
performance status (ps) 0-1 (a measure of the ability to carry out activities of daily living); subjects with ps 2 are eligible if due to disease related symptoms
boolean
C1518965 (UMLS CUI [1])
Cancer treatment Previous | Criteria Fulfill
Item
prior anti-cancer treatment permitted (with specific criteria)
boolean
C0920425 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
C0205156 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Communicable Disease
Item
infection
boolean
C0009450 (UMLS CUI [1])
Triglyceride increased
Item
elevated triglycerides
boolean
C5200999 (UMLS CUI [1])
Gastrointestinal Disease | High risk of Diarrhea | Inflammatory Bowel Diseases
Item
gastro-intestinal disease with increased risk of diarrhea (e.g. inflammatory bowel disease)
boolean
C0017178 (UMLS CUI [1])
C0332167 (UMLS CUI [2,1])
C0011991 (UMLS CUI [2,2])
C0021390 (UMLS CUI [3])
C0332167 (UMLS CUI [2,1])
C0011991 (UMLS CUI [2,2])
C0021390 (UMLS CUI [3])
Bone marrow biopsy Receive Unable
Item
unable to tolerate bone marrow biopsy
boolean
C0005954 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Pharmaceutical Preparations At risk Torsades de Pointes
Item
taking medications known to increase risk of torsades de pointes (an abnormal heart rhythm)
boolean
C0013227 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0040479 (UMLS CUI [1,3])
C1444641 (UMLS CUI [1,2])
C0040479 (UMLS CUI [1,3])